< Back to previous page

Organisation

Nuclear Medicine & Molecular Imaging

Division

Lifecycle:1 Jul 1977  →  Today
Organisation profile:

- Blood cell labelling. - Evaluation of new scintigraphic exploration methods (single photon emission computerized tomography-SPECT). - Scintigraphic evaluation of the effect of fibrinolytic drugs on organ blood supply. - Organic synthesis of ligands for 99m-Tc complexes. - Methodology for radiolabelling, purification and analysis of radioactive drugs. - Tomographic evaluation of tracer distribution (PET, SPECT). - Medical Imaging: acquition, reconstruction PET and SPECT. - Metabolic Imaging in acute and chronic heart disease. - Metabolic Imaging in oncology and inflammation - Neuroactivation studies of the brain. - Radio immunotherapy. - Molecular imaging - Brain imaging in epilepsy and Parkinson's disease. - Image registration (PET, SPECT, MRI, CT).

Keywords:Nuclear medicine, Radiopharmacy, SPECT, PET, Medical Imaging
Disciplines:Medical imaging and therapy, Medicinal products